Title:
AMIDE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2011/078360
Kind Code:
A1
Abstract:
Disclosed is a compound represented by formula (I) or a salt thereof, which has GPR52 agonist activity and is useful as a prophylactic or therapeutic agent for schizophrenia and the like.
(In the formula, ring Cy1 represents a five-membered aromatic heterocyclic ring which may be further substituted in addition to a group represented by -A-B; ring Cy2 represents an optionally substituted benzene ring; ring Cy3 represents an optionally substituted five-membered aromatic heterocyclic ring; ring Cy4 represents an optionally substituted six-membered aromatic ring; A represents -CONRa- or -NRaCO-; Ra represents a hydrogen atom or a substituent; B represents a hydrogen atom or an optionally substituted C1-6 alkyl group; X represents an optionally substituted C1-2 alkylene group, -Y-, -Y-CH2- or -CH2-Y-; Y represents an oxygen atom, -NRb- or -S(O)m-; Rb represents a hydrogen atom or a substituent; and m represents 0, 1 or 2.)
More Like This:
Inventors:
SETOH MASAKI (JP)
TOKUMARU KAZUYUKI (JP)
NAKAHATA TAKASHI (JP)
ISHII NAOKI (JP)
KORI MASAKUNI (JP)
TOKUMARU KAZUYUKI (JP)
NAKAHATA TAKASHI (JP)
ISHII NAOKI (JP)
KORI MASAKUNI (JP)
Application Number:
PCT/JP2010/073426
Publication Date:
June 30, 2011
Filing Date:
December 24, 2010
Export Citation:
Assignee:
TAKEDA PHARMACEUTICAL (JP)
SETOH MASAKI (JP)
TOKUMARU KAZUYUKI (JP)
NAKAHATA TAKASHI (JP)
ISHII NAOKI (JP)
KORI MASAKUNI (JP)
SETOH MASAKI (JP)
TOKUMARU KAZUYUKI (JP)
NAKAHATA TAKASHI (JP)
ISHII NAOKI (JP)
KORI MASAKUNI (JP)
International Classes:
C07D231/56; A61K31/4025; A61K31/4155; A61K31/4178; A61K31/422; A61K31/427; A61P21/02; A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P43/00; C07D405/04; C07D409/04; C07D413/04; C07D417/04
Domestic Patent References:
| WO2009107391A1 | 2009-09-03 | |||
| WO2006138695A1 | 2006-12-28 | |||
| WO2008031594A1 | 2008-03-20 | |||
| WO2006098520A1 | 2006-09-21 | |||
| WO2009107391A1 | 2009-09-03 | |||
| WO2010018874A1 | 2010-02-18 | |||
| WO2009157196A1 | 2009-12-30 | |||
| WO2006116412A2 | 2006-11-02 | |||
| WO2006138695A1 | 2006-12-28 | |||
| WO2008031594A1 | 2008-03-20 |
Foreign References:
| JP2008539247A | 2008-11-13 | |||
| JP2007514768A | 2007-06-07 | |||
| US20050143381A1 | 2005-06-30 |
Other References:
SAWZDARGO ET AL., MOLECULAR BRAIN RESEARCH, vol. 64, 1999, pages 193 - 198
THE CHEMICAL SOCIETY OF JAPAN: "4th Edition Jikken Kagaku Kouza", vol. 19, MARUZEN
"Design of Molecules", vol. 7, 1990, HIROKAWA SHOTEN, article "IYAKUHIN no KAIHATSU", pages: 163 - 198
OKUYAMA ET AL., LIFE SCIENCE, vol. 65, 1999, pages 2109 - 2125
"Japanese Pharmacopoeia"
THE CHEMICAL SOCIETY OF JAPAN: "4th Edition Jikken Kagaku Kouza", vol. 19, MARUZEN
"Design of Molecules", vol. 7, 1990, HIROKAWA SHOTEN, article "IYAKUHIN no KAIHATSU", pages: 163 - 198
OKUYAMA ET AL., LIFE SCIENCE, vol. 65, 1999, pages 2109 - 2125
"Japanese Pharmacopoeia"
Attorney, Agent or Firm:
TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)
Takashima 1 (JP)
Download PDF: